Zhejiang Tianyu Pharmaceutical (300702.SZ): Gliclazide tablets obtained drug registration certificate
Tianyu shares (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (hereinafter referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration (hereinafter referred to as the "NMPA") for Cagrelujet tablets.
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (hereinafter referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" for the drug Kegel Jingtian Tablets issued by the National Medical Products Administration (hereinafter referred to as the "NMPA").
Following the approval from the NMPA, the company's product Kegel Jingtian Tablets can now be produced and sold domestically, further enriching the company's formulation variety and potentially increasing the company's revenue from formulation business. This will also enhance the market competitiveness of the company's products and have a positive impact on the company's performance.
Related Articles
BOSS ZHIPIN-W (02076) repurchased 355,100 shares for $2.5077 million on May 18th.
CISI FIN(06058): Wei Wei appointed as director
On May 19th, Eastroc Beverage (09980) spent 99.98 million yuan to repurchase 682,200 shares of A shares.
BOSS ZHIPIN-W (02076) repurchased 355,100 shares for $2.5077 million on May 18th.
CISI FIN(06058): Wei Wei appointed as director
On May 19th, Eastroc Beverage (09980) spent 99.98 million yuan to repurchase 682,200 shares of A shares.
